Redundancy occurs when an employee is dismissed due to the closure or intended closure of a business or when there is a reduction in the workforce. COVID-19 has caused a huge increase in the numbers of redundancies companies are making across the UK.
Cambridge Consultants has developed EnfuseNet, a breakthrough Artificial Intelligence (AI) system for autonomous vehicles - a low-cost system that generates high-resolution depth data for vehicle perception technology.
Xaar is celebrating its 30th birthday in style with champagne sent to every member of the team to toast the business and its role in pioneering the use of industrial inkjet technologies around the world.
The ‘RECOVERY’ trial has released preliminary results showing lopinavir/ritonavir, an antiviral drug commonly used to treat HIV, had no significant mortality benefit in hospitalised COVID-19 patients.
Innovate UK, part of UK Research and Innovation, has launched a new fund to help cutting-edge companies of all sizes recover, grow, and drive a re-building economy.
The fields of LodeStar, covering 200 acres of fine lawn just outside Cambridge, are opening from mid July to mid August for Covid-19 safe camping.
Most approved “priority” medicines are developed by biotech rather than large pharmaceutical firms, says a two-decade study at the University of Cambridge Judge Business School.
BioStrata, the life science marketing specialist, has appointed two new recruits further advancing the agency’s expert marketing team.
Children whose fathers make time to play with them from a very young age may find it easier to control their behaviour and emotions as they grow up, research suggests.
The Cambridge Folk Festival at Home 2020 will be a celebration of all things Cambridge that you can enjoy from your garden or living room.
Taylor Wessing has advised Swiss Life REIM (France) on the disposal of “Neuer Dovenhof” in Hamburg to Zurich. The net purchase price amounts to approximately EUR 150 million.
It’s hard for any of us to ignore that the world is in the grips of a crisis. It is in times like this of mass uncertainty and economic instability that many Cambridge companies have to make difficult decisions, often leading to redundancies.
PharmEnable, a Cambridge-based drug discovery company using advanced medicinal chemistry and AI-enabled approaches to design the next generation of highly complex and specific drug candidate molecules, announces it has closed a £1.8 million seed financing to support its transition into a drug development company.
CMR Surgical Ltd, the company behind the next-generation surgical robotic system Versius®, today announces a mid-year business update.
As Cambridge City Council works to support the recovery of the city after the impact of Covid-19, a report on council finances suggests the impact on the council could add up to losses of £10m in the current year...
People using mental health services, including children and young people across the country, are set to benefit from a new national research network leading projects to improve practice and care.
Cambridge-based professional services consultancy Green Custard joins an elite group of just 35 companies to achieve AWS CloudFormation Service Delivery Partner status. This award-winning company drives value through creative software solutions and this new AWS CloudFormation Delivery Partner status is recognition of their expertise by the...
In response to the development sector, the Government has published the Business and Planning Bill to extend planning permissions and listed building consents until 1 April 2021. Gemma Dudley of Hewitsons provides the details.
What do we know about covid-19 vaccine candidates under development? What is involved in the vaccine development, trial and innovation process? How will a successful vaccine be distributed?
A new type of artificial heart valve, made of long-lived polymers, could mean that millions of patients with diseased heart valves will no longer require lifelong blood-thinning medication after valve replacement surgery.